美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

生物科技指數ETF-iShares Nasdaq

202.00

-2.5888-1.27%

盤後：203.091.09+0.54%19:59 EDT

成交量：191.74萬

成交額：3.87億

市值：102.92億

市盈率：32.00

高：204.18

開：203.82

低：200.52

收：204.59

52周最高：217.12

52周最低：138.79

股本：5,095.00萬

流通股本：5,095.00萬

量比：1.14

換手率：3.76%

股息：0.40

股息率：0.20%

每股收益(TTM):6.31

每股收益(LYR):35.34

淨資產收益率：24.54%

總資產收益率：0.10%

市淨率：1.26

市盈率(LYR):5.72

資料載入中...

總覽公司新聞資訊公告

英國股市——8月27日需關注的因素

阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標

Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標

【券商聚焦】招銀國際維持藥明生物（02269）「買入」評級指生物類似藥將成新驅動力

歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態

吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌

美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。

Piper Sandler上調安進目標價至457美元

美國研究綜述-安進、Analog Devices、莫德納

復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥

福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？

TradingKey中文

吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光

TradingKey中文

安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光

TradingKey中文

再生元製藥旗下Pasatru獲歐洲藥品管理局審評，全球申報在即

再生元製藥獲FDA批准：Pasatru（Garetosmab-Grts）上市，治療成人進行性骨化性纖維發育不良

異動解讀｜生物科技指數ETF-iShares Nasdaq盤中上漲5.1%，MNC併購加速疊加多重利好共振

瑞穗上調安進目標價至352美元

駿利亨德森投資：專利到期倒逼藥企擴張生物科技併購、IPO市場同步復甦

智通财经网

藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」

TScan Therapeutics披露：安進將終止與其研究合作及許可協議

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/IBB/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","market":"US","secType":"STK","nameCN":"生物科技指數ETF-iShares Nasdaq","latestPrice":202,"timestamp":1789502400000,"preClose":204.5888,"halted":0,"volume":1917353,"hourTrading":{"tag":"盘后","latestPrice":203.09,"preClose":202,"latestTime":"19:59 EDT","volume":3436,"amount":694324.56,"timestamp":1789516769053,"change":1.09,"changeRate":0.005396,"amplitude":0.005396},"delay":0,"changeRate":-0.012653674101417049,"floatShares":50950000,"shares":50950000,"eps":6.311863,"marketStatus":"未開盤","change":-2.5888,"latestTime":"09-15 16:00:00 EDT","open":203.82,"high":204.18,"low":200.52,"amount":387213579.83248,"amplitude":0.01789,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.311863,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789545600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":204.5888,"sharesOutstanding":49450000,"nav":204.610559,"aum":10516982732.6,"dividendRate":0.002,"bidAskSpread":0.000306,"preHourTrading":{"tag":"盘前","latestPrice":203.56,"preClose":204.5888,"latestTime":"07:51 EDT","volume":104,"amount":21178.00568,"timestamp":1789473086311,"change":-1.0288,"changeRate":-0.005029,"amplitude":0.02326},"postHourTrading":{"tag":"盘后","latestPrice":203.09,"preClose":202,"latestTime":"19:59 EDT","volume":3436,"amount":694324.56,"timestamp":1789516769053,"change":1.09,"changeRate":0.005396,"amplitude":0.005396},"volumeRatio":1.137226,"impliedVol":0.2306,"impliedVolPercentile":0.464},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBB\",,,,,undefined,":{"symbol":"IBB","floatShares":50950000,"roa":"0.10%","roe":"24.54%","lyrEps":35.344796,"volumeRatio":1.137226,"shares":50950000,"dividePrice":0.404,"high":204.18,"amplitude":0.01789,"preClose":204.5888,"low":200.52,"week52Low":138.785,"pbRate":"1.26","psRate":"247.61","week52High":217.12,"institutionHeld":0,"latestPrice":202,"eps":6.311863,"divideRate":0.002,"volume":1917353,"delay":0,"ttmEps":6.311863,"open":203.82,"prevYearClose":168.77,"prevWeekClose":202.93,"prevMonthClose":209.05,"prevQuarterClose":190.19,"fiveDayClose":207.33,"twentyDayClose":201.93,"sixtyDayClose":173.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBB\",params:#limit:5,,,undefined,":[{"date":"2026-09-15","symbol":"IBB","amount":0.011194,"announcedDate":"2026-09-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-15","defaultRemindTime":1789479000000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-18","payableDate":"2026-09-15","currency":"USD","dateTimestamp":1789444800000,"payDate":"2026-09-18"},{"date":"2026-06-15","symbol":"IBB","amount":0.023774,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2026-03-17","symbol":"IBB","amount":0.121818,"announcedDate":"2026-03-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-17","defaultRemindTime":1773754200000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-20","payableDate":"2026-03-17","currency":"USD","dateTimestamp":1773720000000,"payDate":"2026-03-20"},{"date":"2025-12-16","symbol":"IBB","amount":0.183099,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-09-16","symbol":"IBB","amount":0.082843,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"生物科技指数ETF-iShares Nasdaq","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-19"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBB\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-26","recordDate":"2016-09-28","paymentDate":"2016-09-30","value":0.0858219,"currency":"USD"},{"executeDate":"2016-12-22","recordDate":"2016-12-27","paymentDate":"2016-12-29","value":0.091903,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.29898,"currency":"USD"},{"executeDate":"2017-06-27","recordDate":"2017-06-29","paymentDate":"2017-06-30","value":0.176803,"currency":"USD"},{"executeDate":"2017-09-26","recordDate":"2017-09-27","paymentDate":"2017-09-29","value":0.118654,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBB\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662775484","title":"英國股市——8月27日需關注的因素","url":"https://stock-news.laohu8.com/highlight/detail?id=2662775484","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662775484?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:53","pubTimestamp":1787813617,"startTime":"0","endTime":"0","summary":"更新 1-英国股市——8月27日需关注的因素新增新闻报导，更新期货行情路透8月27日-预计周四英国富时100指数.FTSE将低开，期货FFIc1下跌0.4%。*7月汽车产量：行业数据显示，受出口疲软及部分工厂提前进行夏季检修停产影响，英国7月汽车产量  同比下降11.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0JK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345780950.USD","GLEN.UK","BIB","IBBQ","LU0949170426.SGD","LU1057294990.SGD","LU0553294199.USD","BK5105","LU1880407132.USD","PJP","SGXZ57979304.SGD","LU0868494617.USD","CRDA.UK","HFD.UK","LU0889565916.HKD","IBB","TBXU","LU0310800379.SGD","BBH","LU1267930227.SGD","BK4585","IE0034235188.USD","LU0211326755.USD","LU1267930573.SGD","LU0171276677.USD","LU0345777147.USD","PBE","PRU.UK","SG9999001176.SGD","LU0122379950.USD","GAW.UK","LU1355424745.HKD","AZN.UK","PPH.UK","LU0047713382.USD","LU0857590862.USD","LU1119994496.HKD","LU2089984988.USD","03165","LU0171293334.USD","LU0969580561.USD","LU0963555726.SGD","LU1989771016.USD","LU1104425308.USD","LU2293690082.USD","LU0075056555.USD","BK4139","LU0792757196.USD","LU1989772923.USD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662639773","title":"阿斯利康的哮喘藥物Tezspire在食管炎晚期臨床試驗中達到了所有目標","url":"https://stock-news.laohu8.com/highlight/detail?id=2662639773","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662639773?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:08","pubTimestamp":1787810905,"startTime":"0","endTime":"0","summary":"阿斯利康的哮喘药物Tezspire在食管炎晚期临床试验中达到了所有目标路透8月27日-阿斯利康（AstraZeneca）AZN.L周四表示，其与安进（Amgen）AMGN.O联合开发的哮喘药物Tezspire，在治疗嗜酸性粒细胞性食管炎（一种食管的慢性炎症性疾病）的晚期临床试验中达到了主要和次要研究目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nL4T44O0GC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0171276677.USD","LU0640478417.SGD","PBE","LU1196032939.SGD","LU0390134368.USD","TBXU","BBH","LU0158827948.USD","LU0211328371.USD","LU0757432116.USD","LU0496365809.HKD","BK4588","AMGN","IBB","LU0203345920.USD","PJP","LU1015430645.USD","LU1064927863.SGD","IE00B2B36J28.USD","BK4139","LU1481599808.USD","LU2089284900.SGD","BK5011","LU1273509221.SGD","LU0823416689.USD","LU0889565916.HKD","LU2237443549.SGD","LU0882574055.USD","LU2357627491.SGD","LU1989772840.SGD","LU0949170426.SGD","LU1061106388.HKD","LU1323610961.USD","LU0011850046.USD","03165","LU1119994496.HKD","IBBQ","LU2125909247.SGD","AZN.UK","LU0557290698.USD","LU0211327993.USD","BIB","LU1261432733.SGD","BK4599","LU0960981461.USD","LU0432979614.USD","LU1267930813.SGD","LU1923622614.USD","LU0526926950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146489142","title":"Tezspire®在嗜酸性食管炎III期臨床試驗中展現積極成果，共同主要終點及所有關鍵次要終點全面達標","url":"https://stock-news.laohu8.com/highlight/detail?id=1146489142","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146489142?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 14:00","pubTimestamp":1787810443,"startTime":"0","endTime":"0","summary":"Tezspire在针对嗜酸性食管炎的III期临床试验中取得了令人瞩目的积极结果。该试验不仅成功达到了共同主要终点，而且所有关键次要终点也悉数告捷。Tezspire的优异表现，标志着该领域治疗可能迎来重大变革。共同主要终点的同时达成，以及关键次要终点的全面覆盖，充分验证了Tezspire的疗效一致性和临床获益的广泛性。业内专家指出，Tezspire的这项研究成果，不仅巩固了其在炎症性疾病治疗领域的地位，更可能为后续的监管审批和市场推广奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","PJP","BBH","LU2242652126.USD","BK4534","LU0868494617.USD","LU2089984988.USD","LU1023059063.AUD","LU0320765992.SGD","LU1057294990.SGD","LU1983299246.USD","BK4533","LU0289739699.SGD","BK4566","IBB","SG9999001440.SGD","BK4599","TBXU","LU0109394709.USD","IBBQ","BK4588","LU1571399168.USD","LU2112291526.USD","BK4139","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0058720904.USD","BIB","IE00BJT1NW94.SGD","IE0009355771.USD","LU0889565916.HKD","IE00B2B36J28.USD","LU1061106388.HKD","AMGN","PBE","LU2468319806.SGD","BK4585","LU2242646821.SGD","LU0122379950.USD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662778813","title":"【券商聚焦】招銀國際維持藥明生物（02269）「買入」評級 指生物類似藥將成新驅動力","url":"https://stock-news.laohu8.com/highlight/detail?id=2662778813","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662778813?lang=zh_tw&edition=fundamental","pubTime":"2026-08-27 13:20","pubTimestamp":1787808047,"startTime":"0","endTime":"0","summary":"金吾财讯 | 招银国际研报指，药明生物 2026年上半年业绩强劲，收入同比增长18.4%至人民币118亿元，经调整净利润增38.4%至33亿元。毛利率升至46.2%，总积压订单达251亿美元。生物类似药将成M端新支柱。公司已有17个生物类似药项目，未来三年已承诺20个项目，80%客户来自全球前十企业。维持“买入”评级。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989738","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","IBB","02269","XPH","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2087621335.USD","IE00B7SZLL34.SGD","TMED","LU2112291526.USD","LU1430594728.SGD","BK4568","BK4139","LU1571399168.USD","IE0002270589.USD","IE00B19Z3581.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1934455863.HKD","LU0234570918.USD","LU0861579265.USD","SG9999015978.USD","LU1037948541.HKD","LU2089984988.USD","LU1934455194.USD","IE00B19Z3B42.SGD","GILD","BMED","IE00BZ1G4Q59.USD","BK4585","LU0289739699.SGD","TBXU","BK4578","LU0859254822.USD","LU0122379950.USD","BK4588","IBB","SG9999015945.SGD","LU2468319806.SGD","LU1057294990.SGD","LU1839511570.USD","LU1061106388.HKD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1585245621.USD","LU0058720904.USD","IE00B3T34201.USD","IBBQ","LU0965509101.SGD","BIB","LU1674673691.USD","BK4532","SG9999015986.USD","LU0320765992.SGD","BBH","LU0965509283.SGD","LU0109394709.USD","LU0965509010.AUD","LU1066051498.USD","LU2357627491.SGD","MEDI","LU2324357040.USD","BK4583","LU1066053197.SGD","LU1674673428.USD","LU0889565916.HKD","SG9999015952.SGD","LU0965508806.USD","BK4550","LU0114720955.EUR","LU0882574055.USD","LU1934455277.USD","LU1037948897.HKD","LU0823416689.USD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","SG9999015945.SGD","LU1934455863.HKD","LU0965509010.AUD","LU2324357040.USD","IE00B3T34201.USD","LU2089984988.USD","BK4568","LU2112291526.USD","LU0965509283.SGD","LU1571399168.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","BK4550","LU0882574055.USD","BK4532","LU2357627491.SGD","BK4588","BK4583","IE00B19Z3581.USD","LU1674673691.USD","LU1061106388.HKD","MEDI","LU0109394709.USD","LU0859254822.USD","LU2468319806.SGD","LU1839511570.USD","LU1674673428.USD","TMED","IBBQ","BK4585","BMED","LU1066053197.SGD","IE00B19Z3B42.SGD","GILD","LU1066051498.USD","LU0122379950.USD","BBH","LU0058720904.USD","BK4566","LU1585245621.USD","IE0002270589.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1778281490.HKD","TBXU","SG9999015978.USD","LU1430594728.SGD","LU0234570918.USD","SG9999015986.USD","LU0965508806.USD","LU1057294990.SGD","LU1037948541.HKD","LU1037948897.HKD","BK4139","LU1934455194.USD","LU0114720955.EUR","BK4578","LU0965509101.SGD","SG9999015952.SGD","IBB","LU0861579265.USD","BIB","LU1023059063.AUD","LU1934455277.USD","LU0823416689.USD","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661291370","title":"美國聯邦貿易委員會（FTC）：安進專利申請收購交易受到反壟斷審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661291370","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661291370?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:49","pubTimestamp":1787327356,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["HCA","EVNT","BWEB","IXP","DRUP","GXPT","PJP","JHCS","MNA","TDAQ","RSPT","NBCC","TRUC","AMGN","IBBQ","CWC","NBDS","GOOX","IEME","IHF","MUSQ","LRGG","PNQI","JHMT","ORCZ","PBE","BBH","EMQQ","PBS","DISC","MSFX","MSFY","TBXU","WEBL","BUYO","GXPC","MRGR","FTC","QQMG","FCOM","GGTL","KEMQ","TGRW","WEBX","ARB","BCTK","IBB","BIB","ONEQ","XLCI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250489","title":"Piper Sandler上調安進目標價至457美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250489","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250489?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:20","pubTimestamp":1787296801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4533","LU2089984988.USD","LU2242652126.USD","BK4585","LU0122379950.USD","LU2242646821.SGD","PJP","LU1023059063.AUD","LU1061106388.HKD","IBBQ","IE0002141913.USD","LU0289739699.SGD","LU1983299246.USD","TBXU","BK4534","AMGN","IE00BFTCPJ56.SGD","PBE","LU1057294990.SGD","IBB","BBH","LU2112291526.USD","LU0889565916.HKD","BK4588","LU0058720904.USD","BIB","LU0109394709.USD","UDN","LU1571399168.USD","UUP","IE00B4R5TH58.HKD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","BK4139","IE00BJT1NW94.SGD","IE0009355771.USD","BK4566","BK4599","LU2468319806.SGD","IE00B2B36J28.USD","BK4581","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660043834","title":"美國研究綜述-安進、Analog Devices、莫德納","url":"https://stock-news.laohu8.com/highlight/detail?id=2660043834","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660043834?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 15:49","pubTimestamp":1787212153,"startTime":"0","endTime":"0","summary":"美国研究综述-安进、Analog Devices、莫德纳路透8月20日-周四，华尔街证券分析师上调了多家在美国上市公司的评级和目标股价，其中包括安进、模拟设备公司和莫德纳。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4S44H0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","LU1720051017.SGD","BK4599","IBB","LU0203345920.USD","LU1989764664.SGD","BK4130","LU1978683503.SGD","LU2506952097.USD","LU1585245621.USD","LU2129689431.USD","LU1989764748.USD","BK4512","IE00B5TLWC47.USD","LU0210528500.USD","BK4588","LU0128525929.USD","LU1804176565.USD","LU1116320737.USD","BK4534","LU0314104364.USD","LU0786609619.USD","LU1430594728.SGD","LU0417517546.SGD","LU0320765646.SGD","LU0472753341.HKD","IYH","HCA","IE00B4R5TH58.HKD","IE00BMPRXR70.SGD","LU1169590202.USD","LU1261432733.SGD","LU0950375773.USD","LU0211331839.USD","SG9999015945.SGD","LU0545039389.USD","IE00BJT1NW94.SGD","LU1066051225.USD","LU0432979614.USD","LU0109394709.USD","LU0130517989.USD","LU0511384066.AUD","LU2237438978.USD","LU1150488135.SGD","LU1989773731.SGD","LU2517655374.HKD","LU1244550577.SGD","LU2244417387.USD","LU1267930490.SGD","LU2272731782.SGD","BK4504","LU0170899867.USD","IE00B19Z9P08.USD","LU0823417653.USD","LU0289739343.SGD","PAWZ","LU0868494617.USD","LU0859254822.USD","IE000M9KFDE8.USD","LU0052756011.USD","LU2242652126.USD","LU0985320562.USD","FAI","LU0203347892.USD","PBE","IE000MB6IJN5.SGD","BK4535","BK4155","LU2347655156.SGD","SG9999015341.SGD","XLV","BK4554","LU1551013342.USD","LU2458330243.SGD","IE0004445239.USD","MRVX","LU2272731865.HKD","LU2360032135.SGD","BK4613","IXJ","LU0130102774.USD","SG9999000418.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014021.USD","LGHT","BK4605","BK4581","LU1670711040.USD","IGV","LU0965509010.AUD","LU1923622291.USD","LU0719512351.SGD","WOLF","SG9999001176.USD","IE0002141913.USD","LU0314106906.USD","LU2275660780.HKD","LU0274383776.USD","LU0823434740.USD","LU2491050071.SGD","MRNY","LU1934455863.HKD","WUGI","CIBR","SOXY","BK4558","TJX","LU1803068979.SGD","MRVL","BK4516","IE00B19Z3B42.SGD","LU0289961442.SGD","IHE","LU2404859741.USD","BK4094","LU2361044865.SGD","LU1074936037.SGD","LU0878866978.SGD","LU2543165471.USD","LU2125909593.SGD","SPAM","IE00BVYPNV92.GBP","LU0029864427.USD","LU1506573853.SGD","CLOD","SG9999014567.USD","LU0266013472.USD","LU1989772923.USD","LU1699723380.USD","LU0444973449.USD","LU0965508806.USD","BK4559","BK4023","LU1489326972.SGD","LU2023250843.SGD","IE000WAW04H5.SGD","LU0077335932.USD","LU0057025933.USD","IE0009356076.USD","IE0004091025.USD","LU1691799644.USD","SG9999015978.USD","WISE","SG9999015358.SGD","LU1674673428.USD","LU2125909759.SGD","LU0868494708.USD","DAT","BK4183","HRTS","LU0097036916.USD","LU2361044949.HKD","LU0795875086.SGD","BK4598","ADI","LU2322448791.USD","SNOW","LU2089984988.USD","IE000F7OJYX1.SGD","IE0000B7K699.USD","TGT","LU1923622614.USD","LU2458330169.SGD","LU1496350502.SGD","LU0823416689.USD","LU1571399168.USD","LU2552382058.USD","LU1093756168.USD","LU0006306889.USD","LU2125909916.SGD","PJP","LU2552382215.SGD","LU2506951958.HKD","LU1712237335.SGD","IE00BZ9MQY76.HKD","LU2491050154.USD","IE00BKVL7J92.USD","BK4551","LU0444971666.USD","LU0949170772.SGD","LU0689626769.HKD","BK4528","LU2092937221.SGD","LU1267930227.SGD","SG9999001176.SGD","LU2357305700.SGD","IE00B775SV38.USD","SG9999014005.SGD","LU1861214812.USD","LU1974910355.USD","BK4604","IHF","IE00B19Z3581.USD","LU1066053197.SGD","LU2237443465.HKD","LU2360107168.USD","MRNA","LU0310800379.SGD","DTCR","FXL","LU1642822529.SGD","LU0211327993.USD","LU1935042991.SGD","BK4083","BK4597","ARTY","LU0265550946.USD","LU2360106780.USD","BIB","LU2360108059.USD","LU1023059063.AUD","TBXU","IE00BDGV0183.EUR","LU1093756325.SGD","IE00BLSP4239.USD","MRVU","RXL","SNOY","SNOU","LU1037948541.HKD","BK4116","QQQA","LU1267930573.SGD","IE00B5949003.HKD","LU0942090050.USD","LU0456855351.SGD","LU1201861249.SGD","LU0943347566.SGD","LU1670628061.USD","CRWD","BK4097","HAKY","BK4560","SG9999014575.USD","LU2041044095.USD","FDTX","SG9999014542.SGD","LU2361045086.USD","IE00BSNM7G36.USD","LU0053666078.USD","BK4501","LU2517655028.SGD","SG9999011175.SGD","LU0690374615.EUR","LU0256863902.USD","BK4503","AIS","LU0477156953.USD","LU1003077747.HKD","LU0912757837.SGD","XNTK","LU0124676726.USD","LU1989763005.USD","LU1548497426.USD","LU2931357623.SGD","LU1066051498.USD","LU0985489474.SGD","LU0106261372.USD","LU1720051108.HKD","LU0310800965.SGD","LU0882574055.USD","LU2237443895.HKD","LU0433182093.SGD","BK4007","BK4141","LU1992135399.USD","BK4185","BK4505","LU2237443622.USD","LU1941712348.USD","LU1983299246.USD","LU2517655291.USD","IE0009355771.USD","BK4561","ABBV","LU0061475181.USD","IE00BMPRXQ63.HKD","LU0965509283.SGD","WDNA","IDNA","IE00B894F039.SGD","LU2125154778.USD","MEDX","IE00BZ1G4Q59.USD","IE00BLSP4452.SGD","LU0081259029.USD","LU1852331112.SGD","IE00B1BXHZ80.USD","JDOC","LU0726765562.USD","IE0034235188.USD","AIPI","LU0265550359.USD","LU0098860793.USD","LU1670627923.USD","LU2089283258.USD","LU1066051811.HKD","LU0823411888.USD","IE00B3S45H60.SGD","FHLC","LU0302445910.USD","LU0823417737.USD","LU2133065610.SGD","LU2487616109.SGD","LU0820561818.USD","LU1929549753.HKD","LU1992135472.HKD","LU0187121727.USD","LU0980610538.SGD","LU2347655073.USD","LU0082616367.USD","LU2298322129.HKD","LU0738911758.USD","LU1988902786.USD","LU1244550221.USD","LU2506951875.HKD","LU0058720904.USD","BK4607","LU2433249047.HKD","VHT","GLAM","LU0320765992.SGD","LU0154236417.USD","BK4566","SGXZ57979304.SGD","LU0070302665.USD","IE00BFTCPJ56.SGD","MRK","04332","MVLL","LU1670710588.SGD","LU2506952170.USD","LU1496350171.SGD","LU2237443549.SGD","LU1244550494.USD","LU1917777945.USD","LU2129689514.USD","IE000BZT7R73.USD","LU2355687059.USD","BK4592","PPH","LU1046421795.USD","LU0128525689.USD","PSWD","LU1778281490.HKD","LU1674673691.USD","LU0795875169.SGD","LU0690374961.EUR","LU1923623000.USD","LU1989772840.SGD","AMGN","LU1150488218.USD","IE00BN8TJ469.HKD","TRUH","SG9999015986.USD","LU1119994496.HKD","LU2357627491.SGD","LU1861220033.SGD","LU1951198990.SGD","LU1069347547.HKD","GTEK","PCTY","CRWC","LU0724618433.USD","IE00B2B36J28.USD","BK4139","LU2125909247.SGD","LU1057294990.SGD","BK4543","BK4568","AIFD","LU2473716301.USD","BK4548","BK4596","LU0094547139.USD","IE0002270589.USD","SG9999014039.USD","XDAT","LU0889565833.HKD","LU1037948897.HKD","LU1732800096.USD","LU0127658192.USD","LU2360107325.USD","LU0823421333.USD","LU2272731600.USD","LU0234572021.USD","LU2264538146.SGD","LU1941712264.USD","SG9999003800.SGD","LU1951200564.SGD","LU2098885051.SGD","AGNG","LU1989771016.USD","LU2404859667.USD","LU0310799852.SGD","LU1303367103.USD","BK4515","GDOC","LU0320765489.SGD","MRNX","LU0861579265.USD","LU2324357040.USD","LU0889565916.HKD","WDAY","BK4585","IBBQ","LU0114720955.EUR","LU0211328371.USD","LU2023250504.SGD","GNOM","LU2237443382.USD","LU1718418525.SGD","LU1823568750.SGD","LU1316542783.SGD","BK4532","LU1861215975.USD","LU2089985449.USD","CLOU","LU1839511570.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0068578508.USD","LU0661504455.SGD","LU2290526834.HKD","LU2112291526.USD","LU1084165304.USD","LU1934455277.USD","LU1861219969.SGD","LU2552382132.HKD","LU2129689605.HKD","LU1162221912.USD","LU2286300806.USD","LU0823421416.USD","LU0158827948.USD","LU0642271901.SGD","LU2125154935.USD","LOW","IE00BMPRXN33.USD","LU0820561909.HKD","IE00B3PB1722.GBP","LU0056508442.USD","BBH","SG9999015952.SGD","LU0208291251.USD","SG9999013999.USD","LU1934455194.USD","LU0957808578.USD","LU2242646821.SGD","LU2237443978.SGD","LU2298321311.HKD","IE0004086264.USD","LU2265009873.SGD","LU0122379950.USD","CRWL","LU0312595415.SGD","LU0069063385.USD","EL","FTXH","BK4550","IE00B42XCP33.USD","LU1670710661.SGD","LU0553294199.USD","LU0648001328.SGD","LU1670711123.USD","LU1935043536.SGD","LU0289739699.SGD","LU2087621335.USD","SG9999014559.SGD","LU0238689110.USD","LU1116320901.HKD","LU1235294995.USD","LU2461242641.AUD","SG9999001440.SGD","LU0234570918.USD","LU1061106388.HKD","IE000SO60NU8.SGD","LU2322448957.HKD","LU2468319806.SGD","BUG","LU2211815571.USD","LU0256863811.USD","BK4533","LU1623119135.USD","LU1035773651.USD","LU2089284900.SGD","SG9999002232.USD","LU0476273544.USD","IE00BD6J9T35.USD","SMHX","LU1815336760.USD","IE00B19Z9Z06.USD","IE00BZ199S13.USD","IE00BVYPNW00.USD","LU0124384867.USD","LU0198837287.USD","BK4114","SG9999014013.SGD","LU0689472784.USD","LU0823434583.USD","LU1732799900.SGD","LU0395794307.EUR","LU1551013425.SGD","LU0109392836.USD","LU0965509101.SGD","LU1169589451.USD","LU1291159041.SGD","IE00BGHQF631.EUR","FTXL","LU1064131342.USD","WCBR","LU2023251221.USD","LU2250418816.HKD","LU0708994859.HKD","SG9999002224.SGD","BILL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660747701","title":"復宏漢霖盤中漲近8% 近期聯手山德士出海至多10款生物類似藥","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747701","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747701?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 10:56","pubTimestamp":1787194560,"startTime":"0","endTime":"0","summary":"模拟交易客户端复宏汉霖盘中涨近8%，截至发稿，股价上涨6.87%，现报70.05港元，成交额1646.58万港元。基于上述首批约定，山德士将向复宏汉霖支付首付款、相关里程碑付款及不可退还的选择权费共计至高3.22亿美元；2026年，复宏汉霖预计可达成的开票金额总计不超过1.005亿美元。值得一提的是，海外市场已成为复宏汉霖业绩增长的重要组成部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-08-20/doc-ininxqxw2099208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HK0000306685.HKD","BK4585","HK0000306701.USD","HK0000165453.HKD","IE00B5TLWC47.USD","LU2272731865.HKD","LU1992135472.HKD","BK1161","BK4588","LU2272731782.SGD","PPH","LU2322448957.HKD","02696","LU2272731600.USD","LU2473716301.USD","HK0000320264.USD","HK0000320223.HKD","LU2322448791.USD","LU1992135399.USD","XPH","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473644","title":"福泰製藥(VRTX)股票8月19日收盤上漲4.48%：釋放什麼信號？","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473644","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473644?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 04:16","pubTimestamp":1787170582,"startTime":"0","endTime":"0","summary":"• 在竞争对手临床试验宣告失败后，福泰制药股价飙升至历史新高。\n• 第二季度营收超出预期，公司同时上调了全年业绩指引。\n• 分析师纷纷给出看涨评级，平均目标价达 563.25 美元。","market":"other","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262119125-market-movers-vrtx-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2236285917.USD","IE00BFTCPJ56.SGD","PBE","BK4139","LU1778281490.HKD","IE0002270589.USD","IE00B19Z3581.USD","LU0234570918.USD","LU1093756325.SGD","IE00B19Z3B42.SGD","IE00B19Z9P08.USD","LU2456880835.USD","SG9999001176.SGD","LU0289739699.SGD","TBXU","LU2237438978.USD","BK4588","IBB","LU2362541513.USD","GNMX","LU2462157665.USD","LU2468319806.SGD","LU0079474960.USD","LU0432979614.USD","LU1035775433.USD","IDNA","VRTX","IE00B4R5TH58.HKD","LU0058720904.USD","LU1585245621.USD","IBBQ","LU2417539215.USD","SGXZ57979304.SGD","BIB","LU1674673691.USD","LU0256863811.USD","BK4532","IE00B19Z9Z06.USD","LU0320765992.SGD","BBH","BK4567","LU0109394709.USD","LU2324357040.USD","LU1674673428.USD","LU2362541273.HKD","LU1069344957.HKD","IE00BJT1NW94.SGD","LU0417517546.SGD","LU0823416689.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660113478","title":"吉利德科學(GILD)股票8月19日盤中上漲3.66%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660113478","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660113478?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 03:17","pubTimestamp":1787167048,"startTime":"0","endTime":"0","summary":"• 得益于HIV产品组合增长加速，吉利德上调了全年销售指引。\n• 联邦法院颁布禁令阻止海外进口，以保护其核心市场份额。\n• 分析师给予“买入”评级，平均目标价为157.79美元。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118864-market-movers-gild-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1674673428.USD","GILD","LU0965509101.SGD","LU0234570918.USD","LU2468319806.SGD","BBH","SG9999015952.SGD","SG9999015986.USD","LU1839511570.USD","LU1037948541.HKD","TMED","IE00B19Z3B42.SGD","LU0965509010.AUD","LU2324357040.USD","BK4139","IBBQ","IE00B7SZLL34.SGD","TBXU","IE0002270589.USD","LU0965508806.USD","LU1023059063.AUD","IE00BZ1G4Q59.USD","BIB","MEDI","IE00BSNM7G36.USD","LU1934455277.USD","LU0058720904.USD","BK4588","BK4550","LU1934455863.HKD","IE00BKVL7J92.USD","LU1057294990.SGD","IBB","SG9999015945.SGD","LU0320765992.SGD","SG9999015978.USD","IE00B19Z3581.USD","BK4568","LU0289739699.SGD","LU1778281490.HKD","LU1934455194.USD","BK4532","LU1585245621.USD","LU1674673691.USD","BK4583","LU1066051498.USD","BK4578","BMED","LU0965509283.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660819420","title":"安進(AMGN)股票8月19日盤中上漲3.19%：背後推手曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2660819420","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660819420?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:16","pubTimestamp":1787163383,"startTime":"0","endTime":"0","summary":"• Argus上调安进目标价，并重申“买入”评级。\n• 第二季度财务业绩超出华尔街的营收和盈利预期。\n• 技术指标显示 MACD 买入信号及 RSI 买入条件。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262118749-market-movers-amgn-20260819","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0868494617.USD","BK4139","LU1571399168.USD","IE00BJT1NW94.SGD","TBXU","LU1983299246.USD","LU0289739699.SGD","BK4533","IE00BFTCPJ56.SGD","BBH","BIB","BK4534","IE00B4R5TH58.HKD","LU0122379950.USD","IE0002141913.USD","LU2089984988.USD","PBE","BK4566","IBB","BK4599","IBBQ","IE00B2B36J28.USD","LU0320765992.SGD","IE0009355771.USD","BK4585","SG9999001440.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2112291526.USD","LU2242652126.USD","LU2242646821.SGD","BK4588","PJP","LU0109394709.USD","BK4581","LU0058720904.USD","LU2468319806.SGD","AMGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105025052","title":"再生元製藥旗下Pasatru獲歐洲藥品管理局審評，全球申報在即","url":"https://stock-news.laohu8.com/highlight/detail?id=1105025052","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105025052?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 02:00","pubTimestamp":1787162410,"startTime":"0","endTime":"0","summary":"再生元制药公司宣布，其研发的药物Pasatru已被欧洲药品管理局纳入审评流程。与此同时，该公司正积极筹备在全球范围内提交该药物的上市申请。欧洲药品管理局的审评启动，为这款药物在欧洲地区的获批前景增添了重要砝码。业界分析认为，Pasatru若能顺利通过审评，有望为相关疾病领域带来新的治疗选择。再生元制药在创新药物研发领域深耕多年，此次针对Pasatru的全球布局，也彰显了其对这一候选药物商业潜力的信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","LU0053666078.USD","LU2362540622.SGD","LU0109394709.USD","LU1917777945.USD","LU0823434740.USD","LU2362541273.HKD","LU0320765992.SGD","LU0289739699.SGD","LU2468319806.SGD","LU2106854487.HKD","LU2362541513.USD","IBBQ","LU1974910355.USD","LU0882574055.USD","BK4588","LU2089984988.USD","TBXU","IBB","LU2023250504.SGD","BBH","BK4585","REGN","LU0058720904.USD","BK4139","LU0823434583.USD","LU0889565916.HKD","LU2237438978.USD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188134905","title":"再生元製藥獲FDA批准：Pasatru（Garetosmab-Grts）上市，治療成人進行性骨化性纖維發育不良","url":"https://stock-news.laohu8.com/highlight/detail?id=1188134905","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188134905?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 01:59","pubTimestamp":1787162353,"startTime":"0","endTime":"0","summary":"再生元制药公司今日宣布，其研发的新药Pasatru已获得美国食品药品监督管理局的正式批准，用于治疗成人进行性骨化性纤维发育不良。这一罕见疾病此前一直缺乏有效的治疗手段，此次获批为患者带来了新的希望。FDA的此次批准基于多项临床研究数据，结果显示Pasatru在减缓异位骨化进展方面表现出显著疗效，且安全性可控。未来，再生元制药计划进一步拓展Pasatru的适应症范围，并探索其在其他相关疾病中的潜在应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU2106854487.HKD","LU0058720904.USD","LU0109394709.USD","LU1974910355.USD","LU1917777945.USD","LU0889565916.HKD","LU0823416689.USD","LU0320765992.SGD","LU2023250504.SGD","LU2362540622.SGD","IBBQ","LU0289739699.SGD","BK4139","BBH","IBB","TBXU","LU0053666078.USD","LU2362541513.USD","BK4588","REGN","LU0823434583.USD","LU0114720955.EUR","LU2362541273.HKD","BK4585","LU2089984988.USD","LU0823434740.USD","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187101531","title":"異動解讀｜生物科技指數ETF-iShares Nasdaq盤中上漲5.1%，MNC併購加速疊加多重利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1187101531","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187101531?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 22:09","pubTimestamp":1787148587,"startTime":"0","endTime":"0","summary":"8月19日，生物科技指数ETF-iShares Nasdaq盘中上涨5.1%，报213.88美元，成交额1.03亿美元。消息面上，生物科技板块近期迎来多重利好共振。另一方面，AI制药订单持续落地驱动生命科学上游需求攀升，板块整体景气度回暖。此外，再生元Libtayo获加拿大卫生部批准用于高危皮肤鳞状细胞癌辅助治疗，进一步提振市场情绪。该ETF追踪纳斯达克生物医疗指数，包含在纳斯达克上市的生物医疗公司，成分和权重可能随时间变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660585446","title":"瑞穗上調安進目標價至352美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2660585446","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660585446?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:55","pubTimestamp":1787129710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","BK4588","LU2242646821.SGD","IE0002141913.USD","LU2242652126.USD","UUP","IE00BJJMRZ35.SGD","LU0289739699.SGD","UDN","BBH","BIB","TBXU","IE00B4R5TH58.HKD","LU1983299246.USD","BK4533","BK4599","LU2089984988.USD","LU0889565916.HKD","LU0058720904.USD","BK4534","LU0868494617.USD","IE00BJT1NW94.SGD","PJP","IBBQ","LU0109394709.USD","LU0122379950.USD","PBE","LU2468319806.SGD","BK4139","LU1023059063.AUD","LU1057294990.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","LU1571399168.USD","IBB","SG9999001440.SGD","IE0009355771.USD","LU0320765992.SGD","AMGN","BK4585","LU2112291526.USD","BK4566","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431564","title":"駿利亨德森投資：專利到期倒逼藥企擴張 生物科技併購、IPO市場同步復甦","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431564","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431564?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 16:06","pubTimestamp":1787126785,"startTime":"0","endTime":"0","summary":"骏利亨德森投资称，尽管利率较市场年初的预期为高，但生物科技行业交易活动的增长动力持续不减。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260819/20260819160606_21666.png?x-oss-process=image/format,jpg/quality,q_60"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1481902.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BIB","BK4585","FBT","IBB","IYG","GTPE","BBC","MRNY","BK4588","BBP","SPCK","MRNX","IWO","BK4582","PBE","IBBJ","IAI","IJT","BIS","JDOC","QSML"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416851","title":"藥代違規進入診療區域！湘雅二醫院發藥品「停用函」，艾力斯、賽諾菲、安進、康蒂尼四藥企上「黑榜」","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416851","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660416851?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 09:48","pubTimestamp":1787104101,"startTime":"0","endTime":"0","summary":"湘雅二医院方面向澎湃新闻表示，院方确有发该“协办函”。据此次公布的协办函，对几家涉事药企的处理决定颇为严厉。近年来，医药代表违规已不仅是行业道德问题，而是监管重点。此次湘雅二医院将企业列入购销负面清单，正是医院端落地上述政策的缩影。湘雅二医院相关负责人表示，自国家在2020年底建立医药代表备案制度，医院就积极响应国家政策，并不断完善内部制度和执行流程。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1787103396417327872","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["IBB","BK4588","BK4581","LU0320765992.SGD","AMGN","LU2242646821.SGD","IE00B4R5TH58.HKD","LU2112291526.USD","LU1571399168.USD","LU0109394709.USD","LU2242652126.USD","BK4534","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","BBH","LU2089984988.USD","BK4566","LU2468319806.SGD","LU1057294990.SGD","688578","BK4533","BK0239","TBXU","BIB","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU0058720904.USD","BK4599","LU0889565916.HKD","IE0009355771.USD","BK4585","PJP","LU1983299246.USD","IBBQ","IE00B2B36J28.USD","LU0868494617.USD","SG9999001440.SGD","IE0002141913.USD","LU0122379950.USD","LU1061106388.HKD","PBE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192416297","title":"TScan Therapeutics披露：安進將終止與其研究合作及許可協議","url":"https://stock-news.laohu8.com/highlight/detail?id=1192416297","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192416297?lang=zh_tw&edition=fundamental","pubTime":"2026-08-19 05:04","pubTimestamp":1787087050,"startTime":"0","endTime":"0","summary":"值得注意的是，安进作为全球领先的生物制药公司，此举无疑将对TScan Therapeutics的研发管线及未来战略布局产生深远影响。TScan Therapeutics方面表示，将仔细评估这一变化对公司在研项目及整体运营带来的潜在影响。对于TScan Therapeutics而言，此番变故或许意味着需要重新校准其研发路径，并探索新的合作机会或资金来源以继续推进其创新疗法的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IBBQ","LU0122379950.USD","LU1571399168.USD","LU0889565916.HKD","AMGN","PJP","BK4533","BK4599","IE0009355771.USD","SG9999001440.SGD","LU0289739699.SGD","LU2242652126.USD","BK4566","IBB","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4534","LU2089984988.USD","BIB","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4139","LU0109394709.USD","LU0320765992.SGD","BK4585","PBE","LU0058720904.USD","LU2468319806.SGD","LU1061106388.HKD","BK4588","BK4539","IE00BJJMRZ35.SGD","IE0002141913.USD","LU1983299246.USD","TCRX","BBH","LU2242646821.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}